Annovis Bio, Inc. (ANVS): Shares Outstanding

Annual figures by period end, from SEC filings.

27.20M
As of 2025-12-31
42.61M
As of 2026-06-30
+49.4%
3-year compound annual growth
+31.6%
5-year compound annual growth
2019-12-31: 282.6K2020-12-31: 6.89M2021-12-31: 8.10M2022-03-31: 8.16M2022-06-30: 8.16M2022-09-30: 8.16M2022-12-31: 8.16M2023-12-31: 10.52M2024-12-31: 14.14M2025-12-31: 27.20M27.20M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3127.20M+92.3%2026-03-13, Balance as of period end
2024-12-3114.14M+34.4%2026-03-13, Balance as of period end
2023-12-3110.52M+28.9%2025-03-21, Balance as of period end
2022-12-318.16Mn/a2024-03-29, Balance as of period end
2022-09-308.16Mn/a2023-03-31, Balance as of period end
2022-06-308.16Mn/a2023-03-31, Balance as of period end
2022-03-318.16Mn/a2023-03-31, Balance as of period end
2021-12-318.10M+17.5%2023-03-31, Balance as of period end
2020-12-316.89Mn/m2022-03-02, Balance as of period end
2019-12-31282.6Kn/a2021-03-03, Balance as of period end